poisar

Stocks · News reference

Citadel Advisors Discloses Increased Stake in Marvell Technology

Fiscal.ai

Citadel Advisors reported a 729% increase in its stake in Marvell Technology, Inc. in a recent 13F filing for the third quarter.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. The Motley FoolErin Kennedy

    Applied Materials vs. Marvell Technology: Which Tech Stock Is a Better Buy for 2027?

    The article compares two semiconductor infrastructure companies: Applied Materials, which manufactures chipmaking equipment, and Marvell Technology, which designs data center networking chips. While Marvell shows faster revenue growth (30.6% vs 21.4%), Applied Materials is recommended as the safer choice due to lower valuation multiples and reduced risk from Marvell's pending $115 billion acquisition of Lumentum Holdings.

  2. The Motley FoolChris Neiger

    Marvell and Intel Are Both Down at Least 50% From Their 2026 Highs. Only 1 Is a Stock I’d Buy.

    Both Marvell Technology and Intel have fallen over 50% from their 2026 highs amid AI spending concerns. Intel's stock collapsed due to disappointing PC and foundry business results, weak guidance, and massive capex spending plans. Marvell, despite a 50% decline from highs, remains the better buy as it shows strong AI chip demand with 37% revenue growth, high profitability (59% gross margin), and minimal capex spending, with projections for 567% revenue growth by 2031.

  3. The Motley FoolJohnny Rice

    Why Marvell Stock Is Down Today

    Marvell stock fell 6.4% on November 16, 2026, as chip stocks broadly declined following Jensen Huang's departure as Nvidia CEO. Investors are rotating out of AI stocks ahead of Nvidia's earnings report. Additionally, Marvell's pending $115 billion all-stock acquisition of Lumentum is creating shareholder dilution concerns.